view counter
 
view counter
 
 

CPMA Issues Withdrawal Guideline Notice

April 7, 2016:

On Thursday, April 7, the Canadian Pari-Mutuel Association issued a notice to the industry stating that the CPMA has received a number of inquiries from industry participants asking about the changes to the withdrawal guidelines for the drugs Clenbuterol and Methylprednisolone....read on

CPMA Delays Implementation Of 2016 Elimination Guidelines

March 31, 2016:

On Thursday, March 31, the Canadian Pari-Mutuel Association issued a release stating that the CPMA is delaying the implementation of the 2016 Elimination Guidelines until May 1, 2016 to allow additional time for the horse racing industry to comply with the changes....read on

Notice Regarding Buprenorphine

May 20, 2015:

The Canadian Pari-Mutuel Agency has issued a notice to the harness racing industry regarding buprenorphine....read on

Reminder: Telmisartan Now Prohibited

September 2, 2014:

On Tuesday, September 2, the Ontario Racing Commission issued a notice to the industry reminding everybody of the Canadian Pari-Mutuel Agency’s Memorandum to the Canadian racing industry and to Provincial Regulatory bodies advising that the drug telmisartan has been added to Schedule of Prohibited Drugs....read on

Telmisartan Added As Prohibited Drug

August 29, 2014:

Please be advised that the regulatory amendment to add the drug telmisartan to the Canadian Pari-Mutuel Agency's (CPMA) Schedule to the Pari-Mutuel Betting Supervision Regulations has been finalized....read on


view counter
 
 
 

© 2020 Standardbred Canada. All rights reserved. Use of this site signifies your agreement and compliance with the legal disclaimer and privacy policy.

Firefox 3 Best with IE 7 Built with Drupal